Showing results (191-200 of 362) with videos related to
Sort By:
Pageof 37
European Journal of Immunology|November 1, 1991
A humanized monovalent CD3 antibody which can activate homologous complementE G Routledge, I Lloyd, S D Gorman, et al.Journal of Autoimmunity|February 1, 1988
Delay in onset of insulitis in NOD mice following a single injection of CD 4 and CD 8 antibodiesA R Hayward, S P Cobbold, H Waldmann, et al.Annals of the Rheumatic Diseases|May 1, 1989
Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritisV Kyle, R J Coughlan, H Tighe, et al.European Journal of Immunology|April 1, 1993
Active suppression induced by anti-CD4P R Hutchings, A Cooke, K Dawe, et al.Therapeutic Immunology|August 1, 1995
Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotypeM G Wing, H Waldmann, J Isaacs, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Regulation of IL-18 (IFN-gamma-inducing factor) gene expressionM Tone, S A Thompson, Y Tone, et al.Bioorganic & Medicinal Chemistry|January 1, 1997
Synthesis of characteristic lipopeptides of the human N-Ras protein and their evaluation as possible inhibitors of protein farnesyl transferaseP Stöber, M Schelhaas, E Nägele, et al.European Journal of Immunology|February 1, 1997
T cell sensitivity to HLA class I-mediated apoptosis is dependent on interleukin-2 and interleukin-4L Genestier, R Paillot, N Bonnefoy-Berard, et al.Lancet (London, England)|June 26, 1993
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapyC M Lockwood, S Thiru, J D Isaacs, et al.Journal of Molecular Biology|June 15, 1999
1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigenL C James, G Hale, H Waldmann, et al.Pageof 37